United States:
Health Care Weekly Preview From Ml Strategies - Week Of July 10, 2017
To print this article, all you need is to be registered or login on Mondaq.com.
Our colleagues at
ML Strategies have provided a
Health Care Weekly Preview. This week?s preview describes the
ongoing wrangling in the Senate over health care reform as well as
highlighting the upcoming need to address
FDA User Fees and the health care
minibus.
Stay tuned for additional updates and analysis from ML
Strategies.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
Planning For The BIOSECURE Act
Foley Hoag LLP
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...
